IL86354A0 - Episomal vector for the expression of selected dna fragments coding for optional polypeptides in mammalian cells and methods for the production thereof - Google Patents

Episomal vector for the expression of selected dna fragments coding for optional polypeptides in mammalian cells and methods for the production thereof

Info

Publication number
IL86354A0
IL86354A0 IL86354A IL8635488A IL86354A0 IL 86354 A0 IL86354 A0 IL 86354A0 IL 86354 A IL86354 A IL 86354A IL 8635488 A IL8635488 A IL 8635488A IL 86354 A0 IL86354 A0 IL 86354A0
Authority
IL
Israel
Prior art keywords
expression
production
methods
mammalian cells
dna fragments
Prior art date
Application number
IL86354A
Other languages
English (en)
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of IL86354A0 publication Critical patent/IL86354A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12N9/1033—Chloramphenicol O-acetyltransferase (2.3.1.28)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16241—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL86354A 1987-05-22 1988-05-12 Episomal vector for the expression of selected dna fragments coding for optional polypeptides in mammalian cells and methods for the production thereof IL86354A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5282787A 1987-05-22 1987-05-22

Publications (1)

Publication Number Publication Date
IL86354A0 true IL86354A0 (en) 1988-11-15

Family

ID=21980163

Family Applications (1)

Application Number Title Priority Date Filing Date
IL86354A IL86354A0 (en) 1987-05-22 1988-05-12 Episomal vector for the expression of selected dna fragments coding for optional polypeptides in mammalian cells and methods for the production thereof

Country Status (10)

Country Link
EP (1) EP0292879A3 (no)
JP (1) JPS63304988A (no)
KR (1) KR880014108A (no)
AU (1) AU604122B2 (no)
CA (1) CA1300052C (no)
DK (1) DK273488A (no)
FI (1) FI882410A (no)
HU (1) HUT47149A (no)
IL (1) IL86354A0 (no)
NO (1) NO882227L (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01108995A (ja) * 1987-10-23 1989-04-26 Hoechst Japan Kk 培養動物細胞による蛋白質の産生を向上させるための遺伝子増幅方法
WO1991000907A1 (en) * 1989-07-05 1991-01-24 Emory University Monocyte chemotactic proteins and related peptides
US5643578A (en) * 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
US5620896A (en) * 1992-03-23 1997-04-15 University Of Massachusetts Medical Center DNA vaccines against rotavirus infections
EP0620277A1 (en) * 1993-03-18 1994-10-19 Merck & Co. Inc. Nucleic acid pharmaceuticals
DE19541450C2 (de) * 1995-11-07 1997-10-02 Gsf Forschungszentrum Umwelt Genkonstrukt und dessen Verwendung
US7091033B2 (en) 2000-07-21 2006-08-15 Phase-1 Molecular Toxicology, Inc. Array of toxicologically relevant canine genes and uses thereof
US7723102B2 (en) * 2000-09-28 2010-05-25 Bayer Corporation Enhanced transfection system
JP2008522589A (ja) 2004-12-03 2008-07-03 ゾーマ テクノロジー リミテッド 組換えタンパク質の発現のための方法及び材料

Also Published As

Publication number Publication date
FI882410A (fi) 1988-11-23
NO882227D0 (no) 1988-05-20
FI882410A0 (fi) 1988-05-20
DK273488D0 (da) 1988-05-19
EP0292879A2 (en) 1988-11-30
CA1300052C (en) 1992-05-05
AU604122B2 (en) 1990-12-06
HUT47149A (en) 1989-01-30
EP0292879A3 (en) 1991-07-03
JPS63304988A (ja) 1988-12-13
DK273488A (da) 1988-11-23
AU1651488A (en) 1988-12-01
NO882227L (no) 1988-11-23
KR880014108A (ko) 1988-12-22

Similar Documents

Publication Publication Date Title
IL73942A0 (en) Method and vector for the production of polypeptides in insect cells
IL87258A0 (en) Kluyveromyces host cells and their use for expressing polypeptides
IL87366A0 (en) Nucleic acid and methods for the synthesis of novel fusion polypeptides
GB2105344B (en) Preparation of polypeptides in vertebrate cell culture
HUT39019A (en) Solid phase process and equipment for the determination of sequence in nucleinic acid fragments
PT86024A (en) Process for preparing nor-statine and nor-cyclostatine polypeptides
NZ221790A (en) Method for the continuous production of a heterologous protein in a eukaryotic host cell
EP0113319A3 (en) Cell lines and their use for the production of proteins
EP0293793A3 (en) Polypeptide and production thereof
PT79917A (en) Process for preparing new renin- inhibotory peptides and their use
PL287811A1 (en) Method of obtaining a vector encoding the nerve growth factor of a nerve subject to expression in eucariotic cells and method of obtaining such nerve growth factor
IL82475A0 (en) Enhanced expression of human interleukin-2 in mammalian cells
IL86354A0 (en) Episomal vector for the expression of selected dna fragments coding for optional polypeptides in mammalian cells and methods for the production thereof
IL96143A0 (en) Methods for the production of proteins and polypeptides and for enhancement of cell growth
EG18596A (en) Process for the preparation of peptide structure and immunogens containing them useful in the control of fertility
ZA892518B (en) Method for the in-vivo production and testing of proteins by recombinant gene expression in selected host-cells
DE3662279D1 (en) Process and apparatus for the readjustment of the operational setting in an electrolysis cell
JPS6443181A (en) Mass cell culture container
EP0116411A3 (en) Dna expression vectors useful in bacillus cells
EP0368926A4 (en) Transfected cells containing plasmids having genes oriented in opposing directions and methods of obtaining the same
JPS6433142A (en) Production of closed cell foam material having high compression strength
IL86277A0 (en) Process for the preparation of foreign proteins in streptomycetes
GB8907110D0 (en) Improvements in the production of polypeptides
AU2912989A (en) Electrolytic cell and process
GB8810524D0 (en) Improvements in production of polypeptides